SBI Securities’s Arcadia Biosciences RKDA Stock Holding History

SBI Securities’s Portfolio RKDA Stock Details RKDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$34	Hold	120	–	–	﹤0.01%	3823
2026 Q2	$81	Hold	120	–	–	﹤0.01%	3556
2026 Q1	$166	Hold	120	–	–	﹤0.01%	3283
2025 Q4	$238	Sell	120 -2	-2%	-$7	﹤0.01%	3156
2025 Q3	$423	Buy	122 +2	+2%	+$8	﹤0.01%	3036
2025 Q2	$517	Hold	120	–	–	﹤0.01%	2952
2025 Q1	$356	Hold	120	–	–	﹤0.01%	3005
2024 Q4	$710	Buy	+120	New	+$494	﹤0.01%	2756

Other funds holding RKDA

BWM

Bullock Wealth Management Bloomington, Indiana $241M AUM 23.31% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

Southern Michigan Bank & Trust Coldwater, Michigan $280M AUM

SBI Securities's RKDA Position: Q3 2026 in Review

SBI Securities held its Arcadia Biosciences (RKDA) position steady in Q3 2026 at 120 shares worth $34. The position accounts for ﹤0.01% of the portfolio, ranked #3823.

SBI Securities first reported a position in RKDA in Q4 2024 and has held it in 8 quarters since. The position peaked at $710 in Q4 2024. 4 funds tracked by Wall St. Rank hold RKDA as of Q3 2026.

SBI Securities held 120 shares of Arcadia Biosciences worth $34 as of Q3 2026.
SBI Securities left its Arcadia Biosciences share count unchanged in Q3 2026.
Arcadia Biosciences made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #3823 holding.
SBI Securities first reported a position in Arcadia Biosciences in Q4 2024 and has held it in 8 quarters since.
SBI Securities's Arcadia Biosciences position peaked at $710 in Q4 2024.
4 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.